Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis. Olsson A, Oturai D, Sørensen PS, Oturai P, Oturai AB Mult Scler. 2015 Jan 26. PMID: 25623251. Abstract CommentRecommendBookmarkWatch